These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38866268)

  • 21. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of nuclear factor kappaB and the effect of topical tacrolimus ointment on lesional atopic dermatitis skin].
    Xie ZQ; Liu LL; Dou X; Wen WJ; Wang D; Zhu XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):487-90. PubMed ID: 15489928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycol chitosan-based renal docking biopolymeric nanomicelles for site-specific delivery of the immunosuppressant.
    Kim CS; Mathew AP; Uthaman S; Moon MJ; Bae EH; Kim SW; Park IK
    Carbohydr Polym; 2020 Aug; 241():116255. PubMed ID: 32507186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical calcineurin and mammalian target of rapamycin inhibitors in inflammatory dermatoses: Current challenges and nanotechnology‑based prospects (Review).
    Sidiropoulou P; Katsarou M; Sifaki M; Papasavva M; Drakoulis N
    Int J Mol Med; 2024 Oct; 54(4):. PubMed ID: 39129316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
    Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model.
    Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY
    Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis.
    Radbruch M; Pischon H; Du F; Haag R; Schumacher F; Kleuser B; Mundhenk L; Gruber AD
    J Control Release; 2022 Sep; 349():917-928. PubMed ID: 35905785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D
    Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease.
    Carroll CL; Fleischer AB
    Expert Opin Pharmacother; 2004 Oct; 5(10):2127-37. PubMed ID: 15461548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis.
    Pople PV; Singh KK
    Int J Pharm; 2010 Oct; 398(1-2):165-78. PubMed ID: 20637847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
    Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A
    Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Buang F; Sahudin S
    Int J Pharm; 2013 Feb; 444(1-2):109-19. PubMed ID: 23337632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment.
    Kahraman E; Aydilek N; Güngör S
    Recent Pat Drug Deliv Formul; 2020; 14(3):191-200. PubMed ID: 32819264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted delivery of tacrolimus to T cells by pH-responsive aptamer-chitosan- poly(lactic-co-glycolic acid) nanocomplex.
    Mansouri A; Abnous K; Alibolandi M; Taghdisi SM; Ramezani M
    J Cell Physiol; 2019 Aug; 234(10):18262-18271. PubMed ID: 30883749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical tacrolimus in the treatment of atopic dermatitis.
    Gianni LM; Sulli MM
    Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical agents for the treatment of atopic dermatitis.
    Diaz A; Guttman-Yassky E
    Expert Rev Clin Immunol; 2019 Apr; 15(4):369-382. PubMed ID: 30587053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug.
    Dong W; Ye J; Wang W; Yang Y; Wang H; Sun T; Gao L; Liu Y
    Int J Nanomedicine; 2020; 15():5629-5643. PubMed ID: 32801706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.